Skip to main content
Technical · 4 min read

Tobacco and Controlled Substance Transactions in Bank Statements: How Lenders Categorise Them

Tobacco and controlled substance transactions in bank statements are categorised as a discretionary expense signal and health risk proxy in Indian NBFC credit underwriting. Detection covers cigarette brands, tobacco retail outlets, and related categories — with a clear distinction between legal tobacco products, prescription medicines, and controlled substances. This article explains how the category works and what it signals.

Terra Insight
Terra Insight Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 23 April 2026
Domain expertise
TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops
Knowledge Card
Problem

Tobacco spending and related controlled substance transactions represent a discretionary expense allocation and potential health risk proxy that, when material relative to income, reduces effective repayment capacity in ways that FOIR from EMI obligations alone does not capture.

How It's Resolved

Match transaction descriptions against cigarette and tobacco brand names, retail outlet names associated with tobacco products, hookah lounge names, and terms associated with controlled substance procurement through non-pharmaceutical channels. Explicitly exclude licensed pharmacy names to prevent false-positive flagging of legitimate healthcare spending.

Configuration

Enable for NBFC and HFC underwriting. Maintain pharmacy whitelist to prevent healthcare misclassification. Review alongside alcohol and gambling signals for complete vice spending aggregate. Set income-share threshold based on lender policy.

Output

Tobacco and controlled substance risk section in the credit report with transaction count, total debit, top five matched terms, and aggregate discretionary allocation across vice spending categories.

The tobacco and controlled substance category in bank statement risk analysis is often the most straightforward of the ten risk word categories to explain: it covers spending on tobacco products and, separately, transactions that indicate controlled substance procurement through non-pharmaceutical channels. The two are distinct — legal tobacco products and pharmacy prescriptions sit on one side; unlicensed procurement patterns sit on the other.

This is a credit risk data point, not a moral assessment.

What the Category Covers

The tobacco component covers detectable spending on tobacco products across India’s distribution channels: branded cigarettes sold through retail, regional tobacco and beedi brands, pan masala and chewing tobacco, hookah lounges, and premium cigar retailers. These transactions appear in bank statements via card swipes at retail outlets, UPI payments to tobacco retailers, and point-of-sale entries at hospitality venues where the primary service includes hookah or tobacco.

The controlled substance component is a narrower and more sensitive detection category. It does not target prescription medicines or pharmacy purchases — those are classified under healthcare spending. It targets narration patterns associated with procurement through non-licensed channels, where the transaction description or counterparty is inconsistent with regulated pharmaceutical or retail supply. This distinction is operationally important: a borrower who regularly purchases medication at Apollo Pharmacy or 1mg is showing healthcare spending, not a controlled substance signal.

The combined category produces a spending aggregate that complements the alcohol, gambling, and luxury detection modules — giving the credit officer a complete view of discretionary spending that may reduce effective repayment capacity.

How Tobacco Transactions Appear in Indian Bank Statements

Indian tobacco spending disperses across several transaction types, making it one of the harder discretionary categories to capture comprehensively at low transaction values.

Branded retail transactions at shops that stock primarily tobacco products appear via UPI payments where the shop name includes the tobacco brand or a recognisable retail naming pattern. In many cases, the merchant name in the bank narration reflects the shop’s UPI ID registered name rather than the brand.

Point-of-sale card transactions at tobacco retail and pan shops appear as small-value card swipes. Below ₹200, many Indian consumers use UPI exclusively — meaning small tobacco purchases are increasingly visible in bank statements through UPI narrations.

Hookah lounges and speciality tobacco retailers appear as restaurant or entertainment point-of-sale entries. Premium establishments appear by name; smaller outlets may appear with generic merchant codes.

Premium tobacco (imported cigarettes, premium cigars) appears via international card transactions at duty-free retailers or via e-commerce platforms that ship internationally.

Tobacco Category Risk Reference

Transaction TypeRecognition ApproachIncome Allocation SignalCredit Context
Branded cigarette retailBrand name + retail outlet pattern matchingLow to moderate per transaction; aggregate mattersAssess as total monthly allocation vs income
Beedi / regional tobaccoRegional brand names + wholesale outlet patternsLow per transactionRelevant in aggregate for income-scarce borrowers
Hookah lounge spendingVenue name matching; hospitality classificationModerate — leisure spending; combine with alcohol signalReview alongside total entertainment spending
Premium / imported tobaccoInternational card debit; duty-free transactionHigh income-relative signal if inconsistent with incomeLifestyle-income consistency check
Controlled substance (non-pharmaceutical)Non-pharmacy counterparty pattern matchingSeparate category — not income allocationLegal and compliance review

India-Specific Context

India’s tobacco retail structure is dominated by small unorganised retailers — pan shops, beedi shops, and general stores. Most transactions at these outlets are UPI payments at amounts typically between ₹20 and ₹300. At these values, individual transactions are rarely material. The credit signal lies in the aggregate pattern: a borrower making 3 to 5 small tobacco-related UPI payments daily over 12 months is showing a consistent discretionary expense that adds up to several thousand rupees per month.

The legal framework for tobacco in India — governed by the Cigarettes and Other Tobacco Products Act (COTPA) 2003 and the National Tobacco Control Programme — does not restrict purchase or possession of tobacco products by adults. The credit risk use of this category therefore does not rely on legal restriction. It relies on income allocation analysis: how much of the applicant’s income is committed to tobacco and related spending, and what does that imply for repayment capacity alongside other obligations.

The Ministry of Finance, Government of India oversees PMLA and the regulatory framework for digital lending. For the controlled substance component of this category, PMLA obligations may be relevant when transactions indicate procurement through unlicensed channels — a compliance review point separate from the credit decision.

The bank statement risk word analysis covers tobacco brand names, retail outlet patterns, and controlled substance indicators, with licensed pharmacy names explicitly excluded to prevent misclassification of healthcare spending.

The bank statement analysis platform presents tobacco spending alongside alcohol, gambling, and luxury categories in a single discretionary spend section — so the credit officer sees the aggregate allocation across all discretionary categories rather than reviewing each in isolation.

Primary reference: Ministry of Finance, Government of India — under whose jurisdiction PMLA and digital lending oversight operates, including guidelines for regulated lenders on customer due diligence and financial profiling.

Frequently Asked Questions

How does tobacco spending appear as a credit risk category in NBFC underwriting?
Tobacco spending is a credit risk category for two reasons. First, it is a discretionary expense that competes with debt servicing. For borrowers with limited disposable income, regular tobacco spending — whether on cigarettes, beedi, chewing tobacco, or similar products — reduces the effective income available for EMI payments. Second, health risk proxies are an input in some lender actuarial models for product pricing, though credit decisions based solely on tobacco use may face regulatory scrutiny. The primary use is income allocation assessment, not health scoring.
What specific tobacco products and brands appear in Indian bank statement detection?
Detection covers cigarette brands (Gold Flake, Classic, Navy Cut, Wills, Marlboro, Four Square, Bristol), beedi brands and regional tobacco suppliers, pan masala and chewing tobacco brands, hookah lounge transactions (which appear as restaurant or entertainment point-of-sale entries), and tobacco retail outlets with recognisable naming patterns. Premium cigar retailers and duty-free tobacco transactions also appear in statements for higher-income profiles. State-operated tobacco retail entities (in states that maintain them) are included.
How is a prescription medicine distinguished from a controlled substance in bank statement analysis?
Prescription medicines — even those classified as controlled substances in other contexts — purchased from licensed Indian pharmacies (Apollo Pharmacy, MedPlus, 1mg, Netmeds, PharmEasy) are treated as healthcare spending, not as controlled substance risk flags. Detection in this category focuses on transactions to entities associated with unlicensed or non-pharmaceutical supply of controlled substances. The practical implementation is that pharmacy names are whitelisted from the controlled substance detection module, so legitimate healthcare spending does not trigger risk flags.
What is the income allocation threshold at which tobacco spending becomes a credit signal?
No universal threshold applies across lenders — credit policy governs the treatment. A common internal benchmark is that tobacco-related debits exceeding 2 to 3% of average monthly income consistently over 3 or more months warrant inclusion in the discretionary spend review. The aggregate picture matters more than a single category: tobacco at 2%, alcohol at 4%, and gambling at 5% combined represent a meaningful share of income that the FOIR calculation does not capture.
Does the controlled substance detection category flag prescription drug purchases at pharmacies?
No. Licensed pharmacy transactions are explicitly excluded from the controlled substance risk category and classified under healthcare spending. The controlled substance detection module focuses on transactions that indicate procurement through non-pharmaceutical channels — transactions to entities that are not licensed pharmacies and whose narration patterns are associated with controlled substance supply. This distinction is important for credit officers to understand: a borrower with high healthcare spending at pharmacy chains is showing a different signal than one showing transactions to unlicensed channels.

See how TransactIG handles reconciliation for your industry

Configuration takes 2–4 weeks. No code development required. ISO 27001:2022 certified.